Neopterin concentrations in fetal and maternal blood: A marker of cell- mediated immune activation

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 1, 1999, Pages 170-173

  Radunovic, Nebojsa ^b   Kuczynski, Edward ^b   Rebarber, Andrei ^b   Nastic, Danica ^b   Lockwood, Charles J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Fetus; Immunity; Macrophage; Neopterin; Pregnancy

Indexed keywords

NEOPTERIN;

ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FETUS BLOOD; HUMAN; INFECTION; INFLAMMATORY DISEASE; MACROPHAGE ACTIVATION; MATERNAL BLOOD; MONOCYTE; NEWBORN SCREENING; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD;

EID: 0032816050     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70455-2     Document Type: Article

References (12)

1. 1. Muller MM, Curtius HC, Herold M, Huber CH. Neopterin in clinical practice. Clin Chim Acta 1991;201:1-16.
2. 2. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allerg Immunol 1993;101:1-6.
3. 3. Radunovic N, Lockwood CJ, Ghidini A, Alvarez M, Berkowitz RL. Is fetal blood sampling associated with increased beta-endorphin release into the fetal circulation? Am J Perinatol 1993;10:112-4.
4. 4. Soothill PW, Nicolaides KH, Rodeck CH, Gamsu H. Blood gases and acid-base status of the human second-trimester fetus. Obstet Gynecol 1986;68:173-6.
5. 5. Forestier F, Daffos F, Galacteroso P, Bradakjian J, Rainaut M, Beuzard Y. Hematological values of 163 normal fetuses between 18 and 30 weeks gestation. Pediatr Res 1986;20:342-6.
6. 6. Niederwieser A, Shintaku H, Hasler T, Curtius HC, Lehmann H, Guardamagna O, et al. Prenatal diagnosis of "dihydrobiopterin synthetase" deficiency, a variant form of phenylketonuria. Eur J Pediatr 1986;145:176-8.
7. 7. Dhondt JL, Hayte JM, Forzy G, Delcroix M, Farriaux JP. Unconjugated pteridines in amniotic fluid during gestation Clin Chim Acta 1986;161:269-73.
8. 8. Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibuergger G, Werner ER, et al. Neopterin, a marker of cell-mediated immune activation in human pregnancy. Int J Fertil 1991;36:372-5.
9. 9. Dhondt JL, Tilmont P, Ringel J, Farriaux JP. Pterins analysis in amniotic fluid for the prenatal diagnosis of GTP cyclohydrolase deficiency. J Inherit Metab Dis 1990;13:879-82.
10. 10. Yoon BH, Jun JK, Romero R, Park KH, Gomez, R, Choi JH, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
11. 11. Oleszczuk J, Wawrzycka B, Maj JG. Interleukin-6 and neopterin levels in serum of patients with preterm labour with and without infection. Eur J Obstet Gynecol Reprod Biol 1997;74:27-30.
12. 12. Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. J Inherit Metab Dis 1990;13:879-82.